JP2010521961A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010521961A5 JP2010521961A5 JP2009554082A JP2009554082A JP2010521961A5 JP 2010521961 A5 JP2010521961 A5 JP 2010521961A5 JP 2009554082 A JP2009554082 A JP 2009554082A JP 2009554082 A JP2009554082 A JP 2009554082A JP 2010521961 A5 JP2010521961 A5 JP 2010521961A5
- Authority
- JP
- Japan
- Prior art keywords
- polyethyleneimine
- concentration
- virus
- sugar
- number average
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229920002873 Polyethylenimine Polymers 0.000 claims 17
- 241000700605 Viruses Species 0.000 claims 14
- 238000000034 method Methods 0.000 claims 14
- 235000000346 sugar Nutrition 0.000 claims 13
- 239000002245 particle Substances 0.000 claims 10
- 150000008163 sugars Chemical class 0.000 claims 4
- 229930006000 Sucrose Natural products 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- 239000000243 solution Substances 0.000 claims 3
- 239000005720 sucrose Substances 0.000 claims 3
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims 2
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims 2
- 239000007864 aqueous solution Substances 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 2
- 239000011159 matrix material Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 238000004321 preservation Methods 0.000 claims 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000002238 attenuated effect Effects 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 claims 1
- 239000006166 lysate Substances 0.000 claims 1
- 229940031348 multivalent vaccine Drugs 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 125000000185 sucrose group Chemical group 0.000 claims 1
- 150000005846 sugar alcohols Chemical class 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0705245.9A GB0705245D0 (en) | 2007-03-19 | 2007-03-19 | Stable biological products |
| US91722007P | 2007-05-10 | 2007-05-10 | |
| PCT/GB2008/000987 WO2008114021A1 (en) | 2007-03-19 | 2008-03-19 | Method for preserving viral particles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010521961A JP2010521961A (ja) | 2010-07-01 |
| JP2010521961A5 true JP2010521961A5 (cg-RX-API-DMAC7.html) | 2011-05-06 |
Family
ID=38008686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009554082A Withdrawn JP2010521961A (ja) | 2007-03-19 | 2008-03-19 | ウイルス粒子を保存するための方法 |
Country Status (18)
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8097245B2 (en) | 2005-12-28 | 2012-01-17 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
| US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
| US8460726B2 (en) | 2006-12-18 | 2013-06-11 | Advanced Bionutrition Corporation | Dry food product containing live probiotic |
| KR20110079670A (ko) * | 2008-09-24 | 2011-07-07 | 스타빌리테크 리미티드 | 슈가 및 폴리에틸렌이민을 사용하여 폴리펩티드를 보존하는 방법 |
| CA2986751A1 (en) | 2009-03-27 | 2010-09-30 | Intervet International B.V. | Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
| JP5804453B2 (ja) * | 2009-05-14 | 2015-11-04 | 国立大学法人 東京大学 | 結晶性ポリオール微粒子及びその調製方法 |
| EP2435554B1 (en) | 2009-05-26 | 2017-07-26 | Advanced Bionutrition Corporation | Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making |
| US9504750B2 (en) | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
| CA2785815C (en) * | 2010-01-28 | 2018-04-24 | Advanced Bionutrition Corporation | Dry glassy composition comprising a bioactive material |
| GB201002419D0 (en) * | 2010-02-12 | 2010-03-31 | Isis Innovation | Stable live vaccine formulations |
| ES2543795T3 (es) | 2010-03-31 | 2015-08-21 | Stabilitech Ltd. | Estabilización de partículas virales |
| WO2011121305A2 (en) | 2010-03-31 | 2011-10-06 | Stabilitech Ltd. | Method for preserving alum adjuvants and alum-adjuvanted vaccines |
| DK2552478T3 (en) * | 2010-03-31 | 2017-03-27 | Stabilitech Ltd | EXCIPIENTS FOR STABILIZING VIRUS PARTICLES |
| NZ607226A (en) | 2010-08-13 | 2015-03-27 | Advanced Bionutrition Corp | Dry storage stabilizing composition for biological materials |
| CN103269716B (zh) | 2010-12-02 | 2015-05-27 | 昂科利蒂克斯生物科技公司 | 冻干病毒制剂 |
| CA2819246C (en) | 2010-12-02 | 2023-04-25 | Oncolytics Biotech Inc. | Liquid viral formulations |
| GB201117233D0 (en) | 2011-10-05 | 2011-11-16 | Stabilitech Ltd | Stabilisation of polypeptides |
| TWI690322B (zh) | 2012-10-02 | 2020-04-11 | 法商傳斯堅公司 | 含病毒的調配物及其使用 |
| GB201406569D0 (en) | 2014-04-11 | 2014-05-28 | Stabilitech Ltd | Vaccine compositions |
| CA3190510A1 (en) | 2014-07-16 | 2016-01-21 | Transgene Sa | Oncolytic virus for expression of immune checkpoint modulators |
| US20180028626A1 (en) | 2015-02-13 | 2018-02-01 | Transgene Sa | Immunotherapeutic vaccine and antibody combination therapy |
| WO2016131945A1 (en) | 2015-02-20 | 2016-08-25 | Transgene Sa | Combination product with autophagy modulator |
| CN108347982A (zh) | 2015-07-29 | 2018-07-31 | 高级生物营养公司 | 用于特殊饮食用途的稳定的干燥益生菌组合物 |
| WO2017035664A1 (en) | 2015-09-02 | 2017-03-09 | Mcmaster University | Enhanced thermal stability for adenoviral vectors through spray drying |
| CA3023022A1 (en) | 2016-05-04 | 2017-11-09 | Transgene Sa | Combination therapy with cpg tlr9 ligand |
| TW201825674A (zh) | 2016-09-09 | 2018-07-16 | 美商艾斯合顧問有限公司 | 表現雙特異性接合分子的溶瘤病毒 |
| US20190328869A1 (en) | 2016-10-10 | 2019-10-31 | Transgene Sa | Immunotherapeutic product and mdsc modulator combination therapy |
| WO2018091680A1 (en) | 2016-11-18 | 2018-05-24 | Transgene Sa | Cowpox-based oncolytic vectors |
| US11626228B2 (en) * | 2016-12-22 | 2023-04-11 | Rogers Corporation | Multi-layer magneto-dielectric material |
| WO2018122088A1 (en) | 2016-12-28 | 2018-07-05 | Transgene Sa | Oncolytic viruses and therapeutic molecules |
| US10617756B2 (en) | 2017-01-05 | 2020-04-14 | Shimojani, LLC | Drug regimen for treatment of cerebral ischemia |
| GB2562241B (en) | 2017-05-08 | 2022-04-06 | Stabilitech Biopharma Ltd | Vaccine compositions |
| WO2018234506A2 (en) | 2017-06-21 | 2018-12-27 | Transgene Sa | PERSONALIZED VACCINE |
| WO2019020543A1 (en) | 2017-07-28 | 2019-01-31 | Transgene Sa | ONCOLYTIC VIRUSES EXPRESSING AGENTS TARGETING METABOLIC IMMUNE MODULATORS |
| US12377142B2 (en) | 2018-03-07 | 2025-08-05 | Transgene | Recombinant pseudocowpoxvirus |
| WO2020011754A1 (en) | 2018-07-09 | 2020-01-16 | Transgene | Chimeric vaccinia viruses |
| US20210345602A1 (en) * | 2018-09-28 | 2021-11-11 | Otsuka Pharmaceutical Factory, Inc | Mammal cell preserving solution containing acarbose or stachyose |
| US12263197B2 (en) | 2018-10-30 | 2025-04-01 | The University Of Tokyo | Oncolytic virus for cancer therapy |
| AU2019412516A1 (en) | 2018-12-28 | 2021-07-15 | Transgene | M2-defective poxvirus |
| WO2020136232A1 (en) | 2018-12-28 | 2020-07-02 | Transgene Sa | Immunosuppressive m2 protein |
| EP3996732A4 (en) * | 2020-04-14 | 2022-08-24 | Spectrum Solutions, LLC | ASSAYS AND METHODS FOR DETECTION OF VIRAL NUCLEIC ACIDS |
| EP4178605A1 (en) | 2020-07-13 | 2023-05-17 | Transgene | Treatment of immune depression |
| KR20230152035A (ko) | 2021-02-01 | 2023-11-02 | 에쓰티 피에이치아이 테라퓨틱스 컴퍼니 리미티드 | 표적 단백질 분해 시스템 및 이의 응용 |
| WO2022246323A1 (en) * | 2021-05-21 | 2022-11-24 | Takeda Vaccines, Inc. | Solid composition, freeze-drying method and glass vial |
| CN113655057A (zh) * | 2021-08-24 | 2021-11-16 | 威世药业（如皋）有限公司 | 一种检测冷冻干燥处理对痘苗病毒毒力影响的设备 |
| WO2023025899A2 (en) | 2021-08-26 | 2023-03-02 | Transgene | Delivery system for targeting genes of the interferon pathway |
| CN114392237B (zh) * | 2021-12-28 | 2024-02-02 | 上海允英生物医药科技有限公司 | 一种冻干病毒制剂及其制备方法 |
| WO2023213764A1 (en) | 2022-05-02 | 2023-11-09 | Transgene | Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf |
| WO2023213763A1 (en) | 2022-05-02 | 2023-11-09 | Transgene | Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab |
| JP2025523573A (ja) | 2022-07-01 | 2025-07-23 | トランジェーヌ | サーファクタントタンパク質－ｄとｔｎｆｓｆのメンバーを含んでなる融合タンパク質 |
| KR20250052416A (ko) | 2022-08-18 | 2025-04-18 | 트랜스진 | 키메라 폭스바이러스 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5459698A (en) * | 1997-11-26 | 1999-06-15 | Universal Preservation Technologies, Inc. | Preservation of sensitive biological samples by vitrification |
| CA2400318C (en) | 2000-02-08 | 2005-06-14 | Allergan, Inc. | Botulinum toxin pharmaceutical compositions |
| US20040110267A1 (en) * | 2000-12-15 | 2004-06-10 | Stratagene | Room temperature stable competent cells |
| GB0502661D0 (en) * | 2005-02-09 | 2005-03-16 | Stabilitech Ltd | A desiccated product |
| RS20080138A (sr) * | 2005-10-07 | 2009-07-15 | Pfizer Products Inc., | Vakcine i metode lečenja influence kod canina |
-
2007
- 2007-03-19 GB GBGB0705245.9A patent/GB0705245D0/en not_active Ceased
-
2008
- 2008-03-19 AU AU2008228086A patent/AU2008228086A1/en not_active Abandoned
- 2008-03-19 HR HR20110814T patent/HRP20110814T1/hr unknown
- 2008-03-19 DK DK08718824.9T patent/DK2121898T3/da active
- 2008-03-19 BR BRPI0808960-4A patent/BRPI0808960A2/pt not_active IP Right Cessation
- 2008-03-19 RU RU2009138344/10A patent/RU2009138344A/ru not_active Application Discontinuation
- 2008-03-19 US US12/531,902 patent/US8313897B2/en not_active Expired - Fee Related
- 2008-03-19 ES ES08718824T patent/ES2370675T3/es active Active
- 2008-03-19 WO PCT/GB2008/000987 patent/WO2008114021A1/en not_active Ceased
- 2008-03-19 KR KR1020097021553A patent/KR20100015613A/ko not_active Withdrawn
- 2008-03-19 AT AT08718824T patent/ATE525455T1/de active
- 2008-03-19 EP EP08718824A patent/EP2121898B8/en not_active Not-in-force
- 2008-03-19 PL PL08718824T patent/PL2121898T3/pl unknown
- 2008-03-19 GB GB0915291A patent/GB2459611B/en not_active Expired - Fee Related
- 2008-03-19 JP JP2009554082A patent/JP2010521961A/ja not_active Withdrawn
- 2008-03-19 CA CA002681182A patent/CA2681182A1/en not_active Abandoned
- 2008-03-19 CN CN200880008926A patent/CN101636486A/zh active Pending
- 2008-03-19 SI SI200830486T patent/SI2121898T1/sl unknown
-
2009
- 2009-09-01 IL IL200671A patent/IL200671A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010521961A5 (cg-RX-API-DMAC7.html) | ||
| RU2009138344A (ru) | Способ консервации вирусных частиц | |
| JP2010511022A5 (cg-RX-API-DMAC7.html) | ||
| WO2010012069A8 (en) | Multivalent vaccines based on papaya mosaic virus and uses thereof | |
| AR053327A1 (es) | Vacunas mejoradas del vsrrp, metodo para preparar y su uso | |
| CN103599734A (zh) | 一种气凝胶材料及其制备方法 | |
| JP2009523771A5 (cg-RX-API-DMAC7.html) | ||
| WO2008094188A3 (en) | Methods and compositions using listeria for enhancing immunogenicity by prime boost | |
| IN2015DN00888A (cg-RX-API-DMAC7.html) | ||
| JP2011518813A5 (cg-RX-API-DMAC7.html) | ||
| NO20082718L (no) | Vaksine | |
| JP2010516763A5 (cg-RX-API-DMAC7.html) | ||
| JP2015524422A5 (cg-RX-API-DMAC7.html) | ||
| WO2009092113A3 (en) | Methods and compositions for the delivery of vaccines to disrupted epithelium | |
| JP2010532656A5 (cg-RX-API-DMAC7.html) | ||
| JP2013523705A5 (cg-RX-API-DMAC7.html) | ||
| WO2010111586A3 (en) | Mucosal immunization | |
| Faidiuk et al. | Virion morphology and structural organization of polyvalent bacteriophages ТT10-27 and kеу | |
| RU2013126074A (ru) | Вакцина против чумы, аденовирусных инфекций, парвовирусного и коронавирусного энтеритов, лептоспироза и бешенства собак | |
| CN217100114U (zh) | 用于成品棒球棒的转运装置 | |
| CN216761775U (zh) | 一种建材生产用便于上下料的建材运输装置 | |
| CN201799119U (zh) | 一种抛掷玩具 | |
| Qu et al. | A common problem in the purification of calicivirus raised by molecular sieving: balance between purification and loss of viral particles | |
| 조성준 | R & D status of the solid sorbent for CO2 capture in high temperature post combustion process | |
| CN108077328A (zh) | 一种缓释驱蚊片 |